ReproCELL Incorporated (TYO:4978)

ReproCELL Statistics

Total Valuation

ReproCELL has a market cap or net worth of JPY 16.85 billion. The enterprise value is 12.14 billion.

Market Cap	16.85B
Enterprise Value	12.14B

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ReproCELL has 94.69 million shares outstanding. The number of shares has increased by 8.58% in one year.

Current Share Class	94.69M
Shares Outstanding	94.69M
Shares Change (YoY)	+8.58%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	4.44%
Owned by Institutions (%)	-1.16%
Float	90.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.95
PB Ratio	1.95
P/TBV Ratio	1.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-96.31
EV / Sales	4.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.94

Current Ratio	9.94
Quick Ratio	9.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1.48% and return on invested capital (ROIC) is -2.24%.

Return on Equity (ROE)	-1.48%
Return on Assets (ROA)	-2.08%
Return on Invested Capital (ROIC)	-2.24%
Return on Capital Employed (ROCE)	-3.52%
Revenue Per Employee	28.63M
Profits Per Employee	-1.27M
Employee Count	99
Asset Turnover	0.31
Inventory Turnover	4.66

Taxes

Income Tax	-56.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.17% in the last 52 weeks. The beta is 0.75, so ReproCELL's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+28.17%
50-Day Moving Average	196.62
200-Day Moving Average	155.14
Relative Strength Index (RSI)	40.39
Average Volume (20 Days)	1,113,970

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ReproCELL had revenue of JPY 2.83 billion and -126.00 million in losses. Loss per share was -1.34.

Revenue	2.83B
Gross Profit	1.52B
Operating Income	-306.00M
Pretax Income	-182.00M
Net Income	-126.00M
EBITDA	-253.75M
EBIT	-306.00M
Loss Per Share	-1.34

Balance Sheet

The company has 4.72 billion in cash and n/a in debt, giving a net cash position of 4.72 billion or 49.84 per share.

Cash & Cash Equivalents	4.72B
Total Debt	n/a
Net Cash	4.72B
Net Cash Per Share	49.84
Equity (Book Value)	8.66B
Book Value Per Share	91.45
Working Capital	4.92B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 53.46%, with operating and profit margins of -10.80% and -4.45%.

Gross Margin	53.46%
Operating Margin	-10.80%
Pretax Margin	-6.42%
Profit Margin	-4.45%
EBITDA Margin	-8.95%
EBIT Margin	-10.80%
FCF Margin	n/a

Dividends & Yields

ReproCELL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.58%
Shareholder Yield	n/a
Earnings Yield	-0.75%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2013. It was a forward split with a ratio of 5.

Last Split Date	Aug 28, 2013
Split Type	Forward
Split Ratio	5

Scores

ReproCELL has an Altman Z-Score of 13.94 and a Piotroski F-Score of 2.

Altman Z-Score	13.94
Piotroski F-Score	2